• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 464477 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414771262 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414771262 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Shares of Acadia Pharmaceuticals Rise Above Previous 52-Week High

Published on Thu, 03/21/2013 - 14:10
By Mallory Stone

Shares of Acadia Pharmaceuticals (NASDAQ:ACAD) traded today at $8.70, breaking its 52-week high. So far today approximately 18.6 million shares have been exchanged, as compared to an average 30-day volume of 1.3 million shares.

In the past 52 weeks, Acadia Pharmaceuticals share prices have been bracketed by a low of $1.29 and a high of $8.70 and are now at $8.67, 572% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 2.3% while the 50-day MA has advanced 1.6%.

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.

Acadia Pharmaceuticals (NASDAQ:ACAD) is currently priced 3.1% above its average consensus analyst price target of $8.40. The stock should find initial support at its 50-day moving average (MA) of $6.02 and further support at its 200-day MA of $3.35.

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Bullish Moving Average Cross by Bank of ...

Bank of Ireland (NYSE:IRE) crossed over its 10-day moving average of $15.76 on a volume ...

Zebra Technologies Shares Climbing Highe...

Zebra Technologies (NASDAQ:ZBRA) is one of today's notable stocks on the rise, up 2.6% ...

Top 3 Companies in the Biotechnology Ind...

Below are the three companies in the Biotechnology industry with the highest projected ...

Republic Services Crosses Below its 10-d...

Today, shares of Republic Services (NYSE:RSG) have fallen below their 10-day MA of $39. ...

Buyers Accumulate Shares of Yum! Brands,...

Yum! Brands (NYSE:YUM) is a company whose shares are active, trading 2.6% higher to $71 ...

Revlon Ranks the Highest in Terms of Pro...

Below are the three companies in the Personal Products industry with the highest projec ...

Under Armour Bullish Moving Average Cros...

Today, shares of Under Armour (NYSE:UA) have advanced above their 10-day MA of $65.07 o ...

Movado Shares Climbing Higher, Up 2.6%...

Movado (NYSE:MOV) is one of today's biggest movers, up 2.6% to $34.85. The Dow is up 1 ...